Log In
Print
BCIQ
Print
Print this Print this
 

IMCgp100, ImmTAC-gp100

  Manage Alerts
Collapse Summary General Information
Company Immunocore Ltd.
DescriptionBispecific biologic comprising a T cell receptor (TCR) specific for melanoma-associated antigen silver homolog (SILV; PMEL17; GP100) fused to an anti-CD3 antibody single-chain variable fragment (scFv)
Molecular Target Silver homolog (SILV) (PMEL17) (GP100)
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today